We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant

Delisted

CYTXW was delisted on the 14th of December, 2018.

5 hedge funds and large institutions have $1.74M invested in Cytori Therapeutics Inc Warrant in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFM
1
Anson Funds Management
Texas
$941K +$302K +450,000 New
SM
2
Sabby Management
Florida
$793K +$674K +1,004,065 New
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$1K +$593 +883 New
KLI
4
Kelman-Lazarov Inc
Tennessee
$160 +$134 +200 New
MCM
5
Manchester Capital Management
Vermont
+$5 +7 New

CYTXW Hedge Fund Activity: Q2 2016 in Review

5 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q2 2016, worth a combined $1.74M.

Buyers outnumbered sellers: 5 funds opened new CYTXW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $674K.

  • 5 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q2 2016, up from 0 in Q1 2016.
  • Funds reported $1.74M of Cytori Therapeutics Inc Warrant stock for Q2 2016.
  • 5 funds opened new Cytori Therapeutics Inc Warrant positions in Q2 2016 and 0 closed out, a net change of +5 holders.
  • The largest Cytori Therapeutics Inc Warrant buyer in Q2 2016 was Sabby Management, an estimated $674K added.

Based on aggregated 13F filings for Q2 2016.